CLINICAL_TRIALS
ClinicalTrials.gov record update
Effects of Anamorelin on Cancer-Related-Fatigue in Patients With Advanced Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03035409
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:59.102248+00:00
- Published At
- 2022-02-03T00:00:00+00:00
- Record Updated At
- 2025-11-10
- Results Posted At
- 2022-02-03
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Advanced Malignant Solid Neoplasm", "C-Reactive Protein Measurement", "Cancer Fatigue", "Metastatic Malignant Solid Neoplasm", "Recurrent Malignant Solid Neoplasm", "Weight Loss"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-10"- protocolSection.identificationModule.nctId
"NCT03035409"- protocolSection.identificationModule.officialTitle
"Effects of Anamorelin on Cancer-Related-Fatigue in Patients With Advanced Cancer"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-02-03"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.